241 related articles for article (PubMed ID: 2994350)
1. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
[TBL] [Abstract][Full Text] [Related]
2. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
Yuhasz SA; Dissette VB; Cook ML; Stevens JG
Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of reactivated latent murine cytomegalovirus infection.
Shanley JD; Jordan MC; Cook ML; Stevens JG
Am J Pathol; 1979 Apr; 95(1):67-80. PubMed ID: 219700
[TBL] [Abstract][Full Text] [Related]
4. Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines.
Sandford GR; Burns WH
J Infect Dis; 1988 Sep; 158(3):596-601. PubMed ID: 2842407
[TBL] [Abstract][Full Text] [Related]
5. Studies of ocular murine cytomegalovirus infection.
Hayashi K; Kurihara I; Uchida Y
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
[TBL] [Abstract][Full Text] [Related]
6. In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment.
Rabinovitch T; Oh JO; Minasi P
Invest Ophthalmol Vis Sci; 1990 Apr; 31(4):657-63. PubMed ID: 2159448
[TBL] [Abstract][Full Text] [Related]
7. Murine models of cytomegalovirus-associated pneumonitis.
Shanley JD
Transplant Proc; 1991 Jun; 23(3 Suppl 3):12-6, discussion 16. PubMed ID: 1648814
[TBL] [Abstract][Full Text] [Related]
8. Murine cytomegalovirus gene amplification and culture after submaxillary salivary gland biopsy.
Schmader KE; Rahija RJ; Porter KR; Hamilton JD
Lab Anim Sci; 1991 Oct; 41(5):396-400. PubMed ID: 1666135
[TBL] [Abstract][Full Text] [Related]
9. Evolution of serum antibodies against different classes of murine cytomegalovirus--induced antigens and virus isolation following a primary infection.
Coppolecchia P; Furlini G; Re MC; Landini MP
Microbiologica; 1983 Apr; 6(2):175-9. PubMed ID: 6306403
[TBL] [Abstract][Full Text] [Related]
10. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
Zhang M; Xin H; Duan Y; Atherton SS
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
[TBL] [Abstract][Full Text] [Related]
11. Investigation of murine cytomegalovirus latency and reactivation in mice using viral mutants and the polymerase chain reaction.
Bevan IS; Sammons CC; Sweet C
J Med Virol; 1996 Apr; 48(4):308-20. PubMed ID: 8699162
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression reactivates and disseminates latent murine cytomegalovirus.
Jordan MC; Shanley JD; Stevens JG
J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus.
Koffron AJ; Mueller KH; Kaufman DB; Stuart FP; Patterson B; Abecassis MI
Scand J Infect Dis Suppl; 1995; 99():61-2. PubMed ID: 8668944
[TBL] [Abstract][Full Text] [Related]
14. Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.
Bartholomaeus WN; O'Donoghue H; Foti D; Lawson CM; Shellam GR; Reed WD
Immunology; 1988 Jul; 64(3):397-405. PubMed ID: 2842252
[TBL] [Abstract][Full Text] [Related]
15. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus.
Tanaka K; Koga Y; Lu YY; Zhang XY; Wang Y; Kimura G; Nomoto K
J Clin Invest; 1994 Sep; 94(3):1019-25. PubMed ID: 8083343
[TBL] [Abstract][Full Text] [Related]
16. Murine cytomegalovirus infection model in Balb/c mice. 3. Immunoglobulin production during infection.
Leung WC; Hashimoto K; Umehara K; Hata J
Tokai J Exp Clin Med; 1991 Mar; 16(1):11-20. PubMed ID: 1664146
[TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
Bale JF; O'Neil ME; Lyon B; Perlman S
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
[TBL] [Abstract][Full Text] [Related]
18. Murine cytomegalovirus infection model in Balb/c mice--1. Virological and pathological profiles in mice inoculated with various virus doses.
Leung WC; Hashimoto K; Hata J
Tokai J Exp Clin Med; 1986 Oct; 11(4):293-301. PubMed ID: 3039695
[TBL] [Abstract][Full Text] [Related]
19. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
Bale JF; O'Neil ME; Folberg R
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
[TBL] [Abstract][Full Text] [Related]
20. Inhalatory infection of mice with influenza A0/PR8 virus. II. Detection of the virus in the blood and extrapulmonary organs.
Franková V; Rychterová V
Acta Virol; 1975 Jan; 19(1):35-40. PubMed ID: 235195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
